Share This Profile
Share this profile on Facebook.
Link to this profile on LinkedIn.
Tweet this profile on Twitter.
Email a link to this profile.
See other services through which you can share this profile.
This profile was last updated on 11/12/15  and contains information from public web pages and contributions from the ZoomInfo community.

Ms. Nancy S. Lurker

Wrong Nancy S. Lurker?

Chief Executive Officer

Phone: (862) ***-****  
Email: n***@***.com
PDI , Inc.
Morris Corporate Center 1, Building A 300 Interpace Parkway
Parsippany , New Jersey 07054
United States

Company Description: PDI Inc. is a provider of contract sales teams to pharmaceutical companies, offering a range of sales support services. In addition to contract sales teams, the...   more

Employment History

Board Memberships and Affiliations


  • BS , biology
    Seattle Pacific University
  • MBA
    University of Evansville
  • M.B.A.
    University of Evansville
  • B.S. , Biology
    Seattle Pacific University
  • BS , biology and chemistry
    Seattle Pacific University
  • B.S. , Biology and Chemistry
    Seattle Pacific University
166 Total References
Web References
With our improved balance sheet following ..., 12 Nov 2015 [cached]
With our improved balance sheet following the close of the deal, we plan to be able to further develop our commercial capabilities as well as bring new products to market, namely BarreGen for Barrett's Esophagus, which we plan to launch in 2016," commented Nancy Lurker, President and Chief Executive Officer of PDI.
"In the third quarter, the combined test volume for our three commercialized molecular diagnostics showed a sequential increase of 13%, including 36% growth from our thyroid tests, building off the momentum from our three managed care wins over the summer months," Ms. Lurker added.
Nancy S. Lurker, 55, is ..., 7 Nov 2015 [cached]
Nancy S. Lurker, 55, is Chief Executive Officer and a director of PDI Inc. Prior to joining PDI in 2008, Ms. Lurker served as Senior Vice President and Chief Marketing Officer of Novartis Pharmaceuticals Corporation and was President and Chief Executive Officer of ImpactRx, Inc. Ms. Lurker also served as Group Vice President-Global Primary Care Products for Pharmacia Corporation , after beginning her career at Bristol-Myers Squibb . Ms. Lurker serves as a director of Auxilium Corporation and was previously a director of ConjuChem Biotechnologies, Inc. and Elan Corporation . Ms. Lurker received a Bachelor of Science magna cum laude in biology from
Corporate Governance - Committee Composition - Investors - Auxilium, 11 April 2015 [cached]
Nancy Lurker Committee Member
Board of Directors, 29 May 2014 [cached]
Nancy Lurker has served as one of our directors since June 2011. She has served as Chief Executive Officer and a director of PDI, Inc. since November 2008. Prior to joining PDI, Ms. Lurker was Senior Vice President and Chief Marketing Officer of Novartis Pharmaceuticals Corporation, the US subsidiary of Novartis AG, where she oversaw a product portfolio in multiple therapeutic areas from June 2006 to December 2007. Prior to that, she served as President and Chief Executive Officer of ImpactRx, Inc. since 2003. From 2000 to 2003, Ms. Lurker served as Group Vice President-Global Primary Care Products for Pharmacia Corporation and as Global and US Vice-President for Detrol from 1998-2000 at Pharmacia. From 1984 to 1998, Ms. Lurker rose from senior sales representative at Bristol Myer Squibb to various product management and business development positions, ultimately becoming Senior Director-Worldwide Cardiovascular Franchise Management of Bristol-Myers Squibb. Ms. Lurker was a director of Elan Pharmaceuticals during 2005 and 2006 and of ConjuChem Biotechnologies Inc. from 2004 to 2006. Ms. Lurker received a BS in Biology with high honors from Seattle Pacific University and an MBA from the University of Evansville. Ms. Lurker's more than 25 years of experience in the life sciences industry brings valuable commercial, operations and general management experience to the Board. In addition, her experience as a director of other publicly held life sciences companies brings further oversight and corporate governance experience to the Board.
DUBLIN, Ireland--(BUSINESS WIRE)--May 18, ... [cached]
DUBLIN, Ireland--(BUSINESS WIRE)--May 18, 2006--Elan Corporation, plc ("Elan") today announces the resignation of Nancy Lurker as a non-executive director of the Company with effect from May 31, 2006. Ms Lurker has been a director of Elan since May 2005. Ms Lurker this week announced that she will be taking up the position of Chief Marketing Officer, Novartis Pharmaceuticals, US.
Other People with the name "Lurker":
Other ZoomInfo Searches
Accelerate your business with the industry's most comprehensive profiles on business people and companies.
Find business contacts by city, industry and title. Our B2B directory has just-verified and in-depth profiles, plus the market's top tools for searching, targeting and tracking.
Atlanta | Boston | Chicago | Houston | Los Angeles | New York
Browse ZoomInfo's business people directory. Our professional profiles include verified contact information, biography, work history, affiliations and more.
Browse ZoomInfo's company directory. Our company profiles include corporate background information, detailed descriptions, and links to comprehensive employee profiles with verified contact information.